ConductScience.org, home
TRPV2: transient receptor potential cation channel subfamily V member 2
API referenceFor AI assistants

Gene · 51393

Papers1,706

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 1,706

Download this page as JSON
TitleJournalYearPMIDFound bySource
Correction to "Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression".ACS Cent Sci202642799159PubTator, text miningPubMed
Characterization of TRPV2-associated pathology in Parkinson's disease and therapeutic modulation using Tranilast.Front Cell Neurosci202642625634PubTator, text miningPubMed
Structural origins of species-specific differences in TRPV2 activation.Nat Commun202642624855PubTator, text miningPubMed
Inactivation Switch for Run-up in TRPV2.Res Sq202642620408PubTator, text miningPubMed
Correction: Novel recombinant protein PK5-Gal-3C enhances the anti-tumor activity of T cells via binding with TRPV2.Cancer Immunol Immunother202642616099PubTator, text miningPubMed
Transient receptor potential vanilloid 2 functions as a directional driver for hepoxilin A3-mediated neutrophil migration.Sci Adv202642536751PubTator, text miningPubMed
Transient receptor potential vanilloid channels in inflammatory bowel diseases: linking inflammation, angiogenesis, and oxidative stress.Inflammopharmacology202642507268PubTator, text miningPubMed
Structural insights and regulatory mechanisms of endogenous modulation of TRPV2 as a potential drug target.Biochem Pharmacol202642498156PubTator, text miningPubMed
Structure-based virtual screening for selective connexin hemichannel blockers: a historical perspective on the discovery of a small organic inhibitor.Front Pharmacol202642428492PubTator, text miningPubMed
Pharmacological modulation of TRPV2 enhances migration and induces Immunoglobulin E (IgE)-independent degranulation of mast cells.Cell Calcium202642424794PubTator, text miningPubMed
Dementia, mood disorders, and aging: Bridging new avenues of care through shared biological pathways.Aging Adv202642370305PubTator, text miningPubMed
Sensing force to make platelets: TRPV2 and TRPV4 as complementary regulators of platelet biogenesis.J Thromb Haemost202642315229PubTator, text miningPubMed
Ultra short waves alleviate ulcerative colitis via TRPV2 mediated-macrophage polarization.iScience202642205697PubTator, text miningPubMed
Thermosensitive TRP channels as dietary modulators of adipose thermogenesis: Implications for energy homeostasis and obesity.J Therm Biol202642102493PubTator, text miningPubMed
Defining AV2-1 as a novel pharmacological probe to target human and rodent TRPV2.Br J Pharmacol202641913383PubTator, text miningPubMed
Transient receptor potential vanilloid 2 and 4 are both required for effective platelet formation.J Thromb Haemost202641905497PubTator, text miningPubMed
The Therapeutic Crossroad Between Mitochondria and Cannabidiol: A Mini-Review.Biology (Basel)202641892270PubTator, text miningPubMed
Pathological roles of transient receptor potential channels in chronic obstructive pulmonary disease: special focus on cellular mechanisms.Expert Rev Respir Med202641886309PubTator, text miningPubMed
Inhibition of transient receptor potential vanilloid 1 (TRPV1) by a novel selective antagonist for anti-nociceptive effect on inflammatory pain without hyperthermia.PLoS One202641880378PubTator, text miningPubMed
Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis.ACS Chem Biol202641879799PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/51393/papers

API referenceFor AI assistants